59th ASH Annual Meeting Wrap-up: Hotlanta Freezes Over
2017 ASH News Daily Editor-in-Chief Dr. Saad Usmani recaps the 2017 ASH annual meeting which took place in Atlanta.
Predicting Responses to Gemtuzumab Ozogamicin
Dr. Raetz looks at the use of gemtuzumab ozogamicin (CO) for the treatment of acute myeloid leukemia in adults and children.
In his final President's Column as ASH President, Dr. Ken Anderson provides a thorough overview of ASH's research agenda including topics such as precision medicine, improving the state of care for VTE, epigenetic mechanisms, and stem cell biology and regenerative medicine.
Dr. Ken Anderson discusses ASH's role in health care reform.
Dr. Anderson outlines six major ASH strategic initiatives and goals for the coming years discussed at the 2017 Executive Committee Spring Retreat in Canada.
Dr. Anderson discusses ASH's plan to participate in the "March for Science" to advocate for innovation and education through adequate research funding.
Dr. Anderson offers insight into ASH's policy statements during this politically contentious time.
In his first President's Column, Dr. Kenneth Anderson speaks about ASH's commitment to education and to spreading awareness on important treatment advances and unprecedented scientific discoveries.
In his final President's Column, Dr. Abrams sheds light on the many great accomplishments ASH has achieved during 2016 as well as important initiatives on the horizon that ASH members have made possible this year.
Dr. Abrams talks about the importance of ASH's effort to promote diversity through its Minority Recruitment Initiative's programs.
Dr. Abrams talks about the ASH executive committee's experience in Havana, Cuba during this year's retreat.
Dr. Charles Abrams discusses the "National Cancer Moonshot" which covers advancements in cancer therapy that are currently underway and ASH's efforts in influencing this dialogue.
November-December 2017Volume 14, Issue 6
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology